Atypical antipsychotics: is their higher cost worth it?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1468, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost sharing of antiasthmatics in children − is it really worth it?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 651, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Atypical Antipsychotics for Neuropsychiatric Symptoms of Dementia: Malignant or Maligned?

By Herrmann Nathan   Lanctôt Krista L.  

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 833-843

Adis International

Access to resources Recommend Favorite

Do Atypical Antipsychotics Cause Stroke?

By Nathan Herrmann   Krista L. Lanctôt  

CNS Drugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 91-103

Adis International

Access to resources Recommend Favorite

Off-Label Use of Atypical Antipsychotics: Cause for Concern?

By McKean Andrew  

CNS Drugs, Vol. 26, Iss. 5, 2012-05 ,pp. : 383-390

Adis International

Access to resources Recommend Favorite

Atypical antipsychotics cause diabetes mellitus in schizophrenia?

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite